CD24 and myalgic encephalomeyelitis/chronic fatigue syndrome: Although CD24 plays a well-described role in early B cell development in the bone marrow in mice and man, our novel finding of increased CD24 on B cells as a potential biomarker for ME/CFS patients prompted the investigation of its possible function throughout B cell maturation in the periphery.